ArticleJournal of translational medicine2024

Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.

Lijie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.